• $2.3M
    Market Cap
  • -42.39%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 34
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.005
$0.006
$0.005
1-Year Range
$0.004
$0.010
$0.005
Latest Close$0.005
Change
-$0.0005 (-8.53%)
Volume117,000
Market Cap$2.3M
Shares Outstanding391.6M
P/E (TTM)-5.75
Diluted EPS (TTM)-$0.001
Enterprise Value$2.3M

Information as of 06/01/2026

Company Profile

$2.3M
Market Cap
-$376,176.00
Net Income
Sector: Healthcare
Industry: Biotechnology
109 W Main St, Dalton, OH, United States, 44618
330 455 4971

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Key Executives

  • Michael Richard Guzzetta

Current Ownership Distribution

  • Other306.6M (78.31%)
  • Insiders84.0M (21.44%)
  • Institutions979,888 (0.25%)
  • Mutual Funds0 (0.00%)